Experimental Heart Drug Fails Key Trial Milestone

A closely watched clinical trial for pelacarsen, an experimental therapy developed by Novartis and Ionis to treat heart disease, failed to meet its primary efficacy endpoint. The setback has surprised many cardiologists who had anticipated positive outcomes from the study.